Alba Jene-Sanz
Alba Jene-Sanz
Dirección de correo verificada de upf.edu
TítuloCitado porAño
IntOGen-mutations identifies cancer drivers across tumor types
A Gonzalez-Perez, C Perez-Llamas, J Deu-Pons, D Tamborero, ...
Nature methods 10 (11), 1081-1082, 2013
3322013
IntOGen: integration and data mining of multidimensional oncogenomic data
G Gundem, C Perez-Llamas, A Jene-Sanz, A Kedzierska, A Islam, ...
Nature methods 7 (2), 92-93, 2010
1022010
The mutational landscape of chromatin regulatory factors across 4,623 tumor samples
A Gonzalez-Perez, A Jene-Sanz, N Lopez-Bigas
Genome biology 14 (9), r106, 2013
822013
Expression of polycomb targets predicts breast cancer prognosis
A Jene-Sanz, R Váraljai, AV Vilkova, GF Khramtsova, AI Khramtsov, ...
Molecular and cellular biology 33 (19), 3951-3961, 2013
322013
Inhibition of specific NF-κB activity contributes to the tumor suppressor function of 14-3-3σ in breast cancer
J Ingles-Esteve, M Morales, A Dalmases, R Garcia-Carbonell, ...
PloS one 7 (5), 2012
182012
457: Diversity of methylation patterns in HPV16 LCR in cervical cancer
S Amaro-Filho, AC Brant, JP Vidal, SP Felix, CR Bonvincino, ...
European Journal of Cancer 50, S110-S111, 2014
12014
455: The role of new cancer hallmarks in tumorigenesis
A Gonzalez-Perez, A Jene-Sanz, D Tamborero, N Lopez-Bigas
European Journal of Cancer 50, S110, 2014
2014
EZH2 expression in different subtypes of human breast cancer
GF Khramtsova, AB Islam, AI Khramtsov, P Lyman, L Chuanhong, ...
Cancer Research 72 (8 Supplement), 1061-1061, 2012
2012
Inhibition of Specific NF-kB Activity Contributes to the Tumor Suppressor Function of 14-3-3s in Breast Cancer
J Ingles-Esteve, M Morales, A Dalmases, R Garcia-Carbonell, ...
2012
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–9